Controversies on the role of 5-HT2C receptors in the mechanisms of action of antidepressant drugs

Neuroscience and Biobehavioral Reviews

Volumn 42, Issue , 2014, Pages 208-223

  Martin, Cedric B P ^a,b,c   Hamon, Michel ^a,b,c   Lanfumey, Laurence ^a,b,c   Mongeau, Raymond ^a,c,d  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d EA4475 Pharmacologie de la circulation cérébrale   (France)

Author keywords

5 HTT; Anxiety; Depression; Editing; Splicing; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; MESSENGER RNA PRECURSOR; SEROTONIN 2C RECEPTOR;

ANXIETY; ANXIETY DISORDER; BRAIN REGION; DEFENSIVE BEHAVIOR; DEPRESSION; DISEASE MODEL; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; EMOTIONAL STRESS; FEEDING BEHAVIOR; HORMONE RELEASE; HUMAN; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOTOR ACTIVITY; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; REVIEW; RNA EDITING; ANIMAL; BRAIN; DEPRESSIVE DISORDER; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BRAIN; DEPRESSIVE DISORDER; HUMANS; RECEPTOR, SEROTONIN, 5-HT2C; STRESS, PSYCHOLOGICAL;

EID: 84897841891     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.03.001     Document Type: Review

References (190)

1. Abbas A.I., Urban D.J., Jensen N.H., Farrell M.S., Kroeze W.K., Mieczkowski P., Wang Z., Roth B.L. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res. 2010, 38:e118.
2. 2C receptors. Biol. Psychiatry 1996, 39:1000-1008.
3. 2C receptors. J. Neurochem. 1995, 64:2473-2479.
4. (2C) agonists into ventral but not dorsal hippocampus. Behav. Pharmacol. 2004, 15:37-43.
5. Anders S., Tanaka M., Kinney D.K. Depression as an evolutionary strategy for defense against infection. Brain Behav. Immun. 2013, 31:9-22.
6. 2C receptors, respectively. Neuropsychopharmacology 1995, 13:1-8.
7. 2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses. J. Biol. Chem. 2000, 275:23620-23626.
8. Bagdy G., Arato M. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects. Psychopharmacology 1998, 136:342-348.
9. 1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol 2001, 4:399-408.
10. 2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur. J. Pharmacol. 1995, 275:301-305.
11. Bakish D., Lapierre Y.D., Weinstein R., Klein J., Wiens A., Jones B., Horn E., Browne M., Bourget D., Blanchard A. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder. J. Clin. Psychopharmacol. 1993, 13:409-414.
12. 2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology 2011, 63:160-168.
13. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 1994, 269:11687-11690.
14. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mössner R., Westphal H., Lesch K.-P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 1998, 53:649-655.
15. Benjamin J., Greenberg B.D., Murphy D.L. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects. Psychopharmacology 1996, 127:140-149.
16. Bertaina-Anglade V., la Rochelle C.D., Boyer P.-A., Mocaër E. Antidepressant-like effects of agomelatine (S20098) in the learned helplessness model. Behav. Pharmacol. 2006, 17:703-713.
17. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
18. 2C receptor pre-mRNA editing and expression of the alpha subunit of the heterotrimeric G-protein Gq. J. Neurosci. 2007, 27:1467-1473.
19. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology 1986, 25:1267-1271.
20. Boadle-Biber M.C., Singh V.B., Corley K.C., Phan T.H., Dilts R.P. Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat. Brain Res. 1993, 628:105-114.
21. (2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br. J. Pharmacol. 2006, 149:861-869.
22. 2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br. J. Pharmacol. 2003, 139:998-1004.
23. Boothman L.J., Sharp T. A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control. Neuroreport 2005, 16:891-896.
24. 1A autoreceptors evokes strong anti-depressant-like effects. Mol. Psychiatry 2012, 17:612-623.
25. (1A) receptor antagonist WAY 100,635, in the rat. Neuropharmacology 2000, 39:1222-1236.
26. 2C gene. Biol. Psychol. 2012, 89:94-98.
27. Buczek Y., Tomkins D.M., Higgins G.A., Sellers E.M. Dissociation of serotonergic regulation of anxiety and ethanol self-administration: a study with mCPP. Behav. Pharmacol. 1994, 5:470-484.
28. (2C) receptor antagonist. Biol. Psychiatry 2007, 62:1111-1118.
29. 2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice. Int. J. Neuropsychopharmacol. 2009, 12:793-803.
30. 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res. 2003, 993:1-9.
31. 2C receptor produced by alternative splicing. Mol. Pharmacol. 1996, 50:799-807.
32. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Serotonin function in anxiety, II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 1987, 92:14-24.
33. 2C receptor in glial cells. Brain Res. Bull. 1995, 38:153-159.
34. 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol. Psychiatry. 2010, 67:339-345.
35. Christianson J.P., Drugan R.C., Flyer J.G., Watkins L.R., Maier S.F. Anxiogenic effects of brief swim stress are sensitive to stress history. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 44:17-22.
36. Christianson J.P., Greenwood B.N. Stress-protective neural circuits: not all roads lead through the prefrontal cortex. Stress 2014, 17:1-12.
37. 2C receptor protein in the rat CNS. Neuropharmacology 2000, 39:123-132.
38. Conn P.J., Sanders-Bush E., Hoffman B.J., Hartig P.R. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4086-4088.
39. Cornélio A.M., Nunes-de-Souza R.L. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behav. Brain Res. 2007, 178:82-89.
40. (2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 2004, 29:1782-1789.
41. Cremers T.I.F.H., Rea K., Bosker F.J., Wikstrom H.V., Hogg S., Mørk A., Westerink B.H.C. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology 2007, 32:1550-1557.
42. Cryan J.F., Lucki I. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J. Pharmacol. Exp. Ther. 2000, 295:1120-1126.
43. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 2005, 29:571-625.
44. 2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 2004, 474:364-378.
45. de Mello Cruz A.P., Pinheiro G., Alves S.H., Ferreira G., Mendes M., Faria L., Macedo C.E., Motta V., Landeira-Fernandez J. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 2005, 182:345-354.
46. Dekeyne A., Mannoury la Cour C., Gobert A., Brocco M., Lejeune F., Serres F., Sharp T., Daszuta A., Soumier A., Papp M., Rivet J.-M., Flik G., Cremers T.I., Muller O., Lavielle G., Millan M.J. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 2008, 199:549-568.
47. 2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization. J. Pharmacol. Exp. Ther. 2012, 340:765-780.
48. 2C receptor RNA splicing in suicide: association with editing. Neuroreport 2008, 19:379-382.
49. Dremencov E., Mansari el M., Blier P. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J. Psychiatry Neurosci. 2009, 34:223-229.
50. 2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment. Neuropharmacology 2005, 48:34-42.
51. 2C receptor pre-mRNA: effects of the Morris Water Maze. Gene 2007, 391:186-197.
52. Durand M., Mormède P., Chaouloff F. Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP. Behav. Pharmacol. 2003, 14:173-177.
53. 2C receptor pre-mRNA editing. J. Neurosci. 2005, 25:648-651.
54. (2C) receptor knockout mice. Neuropharmacology 2009, 57:259-267.
55. Fone K.C., Austin R.H., Topham I.A., Kennett G.A., Punhani T. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Br. J. Pharmacol. 1998, 123:1707-1715.
56. 2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacology 1996, 123:346-352.
57. Fox M.A., Andrews A.M., Wendland J.R., Lesch K.-P., Holmes A., Murphy D.L. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology 2007, 195:147-166.
58. Freo U., Holloway H.W., Greig N.H., Soncrant T.T. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology 1992, 107:30-38.
59. Gavarini S., Becamel C., Altier C., Lory P., Poncet J., Wijnholds J., Bockaert J., Marin P. Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability. Mol. Biol. Cell 2006, 17:4619-4631.
60. Ghaziuddin N., King C.A., Welch K.B., Zaccagnini J., Weidmer-Mikhail E., Mellow A.M., Ghaziuddin M., Greden J.F. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion. Psychiatry Res. 2000, 95:183-194.
61. 2C receptors but not by sympathomimetic effects. Neuropharmacology 1994, 33:457-465.
62. Gibson E.L., Barnfield A.M.C., Curzon G. Dissociation of effects of chronic diazepam treatment and withdrawal on hippocampal dialysate 5-HT and mCPP-induced anxiety in rats. Behav. Pharmacol. 1996, 7:185-193.
63. (2B) receptors. Behav. Pharmacol. 2001, 12:613-620.
64. 2C receptors in mice. Eur. J. Pharmacol. 1998, 341:135-138.
65. 2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 1999, 38:315-317.
66. (2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 2000, 36:205-221.
67. Gomes K.S., Nunes-De-Souza R.L. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1261-1269.
68. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci. Biobehav. Rev. 2004, 28:239-259.
69. (2C) receptors in the rat choroid plexus. Behav. Pharmacol. 1994, 5:642-645.
70. 1A receptor is not involved in emotional stress-induced rises in stress hormones. Pharmacol. Biochem. Behav. 1996, 55:303-308.
71. Gudelsky G.A., Koenig J.I., Jackman H., Meltzer H.Y. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors. Psychopharmacology 1986, 90:403-407.
72. Guidotti G., Calabrese F., Auletta F., Olivier J., Racagni G., Homberg J., Riva M.A. Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. Neuropsychopharmacology 2012, 37:746-758.
73. Gurevich I., Englander M.T., Adlersberg M., Siegal N.B., Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J. Neurosci. 2002, 22:10529-10532.
74. 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002, 34:349-356.
75. Hamik A., Peroutka S.J. 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol. Psychiatry 1989, 25:569-575.
76. Hammack S.E., Cooper M.A., Lezak K.R. Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders. Neuropharmacology 2012, 62:565-575.
77. 2C receptors on the acquisition and expression of conditioned defeat in Syrian hamsters. Behav. Neurosci. 2012, 126:530-537.
78. 2C receptor stimulation. J. Neurosci. 2007, 27:6956-6964.
79. (2C) receptor mutant mice. J. Neurosci. 2000, 20:RC71.
80. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 1998, 28:370-490.
81. 2C receptor in human postmortem brains of major mental disorders. Neurosci. Lett. 2003, 346:169-172.
82. 1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur. J. Pharmacol. 1993, 231:223-229.
83. Jørgensen H., Knigge U., Kjaer A., Vadsholt T., Warberg J. Serotonergic involvement in stress-induced ACTH release. Brain Res. 1998, 811:10-20.
84. Kahn R.S., Wetzler S., van Praag H.M., Asnis G.M., Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res. 1988, 25:101-104.
85. Kahn R.S., Wetzler S., Asnis G.M., Kling M.A., Suckow R.F., van Praag H.M. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Res. 1991, 37:25-34.
86. 2C receptor mRNAs results in energy dissipation and loss of fat mass. J. Neurosci. 2008, 28:12834-12844.
87. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 1997, 74:299-316.
88. Kennedy A.J., Gibson E.L., O'Connell M.T., Curzon G. Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. Psychopharmacology 1993, 113:262-268.
89. Kennett G.A., Lightowler S., de Biasi V., Stevens N.C., Wood M.D., Tulloch I.F., Blackburn T.P. Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function. Neuropharmacology 1994, 33:1581-1588.
90. Kennett G.A., Wood M.D., Bright F., Trail B., Riley G., Holland V., Avenell K.Y., Stean T., Upton N., Bromidge S., Forbes I.T., Brown A.M., Middlemiss D.N., Blackburn T.P. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 1997, 36:609-620.
91. Kessler R.C., Nelson C.B., McGonagle K.A., Liu J., Swartz M., Blazer D.G. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br. J. Psychiatry. Suppl. 1996, 17-30.
92. (2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats. Eur. J. Pharmacol. 2008, 589:157-162.
93. Kingsley J.D., Dou H., Morehead J., Rabinow B., Gendelman H.E., Destache C.J. Nanotechnology: a focus on nanoparticles as a drug delivery system. J. Neuroimmune Pharmacol. 2006, 1:340-350.
94. Kontis D., Boulougouris V., Papakosta V.M., Kalogerakou S., Papadopoulos S., Poulopoulou C., Papadimitriou G.N., Tsaltas E. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder. Psychopharmacology 2008, 200:597-610.
95. 2C receptors in the rat choroid plexus. Neuropsychopharmacology 1996, 15:143-151.
96. 2C receptor in Sf9 cells. Mol. Pharmacol. 1995, 48:150-159.
97. 2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 2008, 149:1323-1328.
98. 2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiatry 2001, 6:579-585.
99. Li B., Dong L., Wang B., Cai L., Jiang N., Peng L. Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. Neurochem. Res. 2012, 37:2480-2495.
100. Li Q., Brownfield M.S., Battaglia G., Cabrera T.M., Levy A.D., Rittenhouse P.A., van de Kar L.D. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). J. Pharmacol. Exp. Ther. 1993, 266:836-844.
101. Li Q., Wichems C.H., Ma L., Van De Kar L.D., Garcia F., Murphy D.L. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J. Neurochem. 2003, 84:1256-1265.
102. Liposits Z., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 1987, 86:541-549.
103. (2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res. 2000, 873:34-45.
104. 2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 2007, 146:1677-1688.
105. 2-like receptor expression in brain, heart and intestine. FEBS Lett. 1992, 312:203-207.
106. 2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA. Synapse 2001, 42:12-26.
107. (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J. Neurosci. Res. 2002, 67:69-85.
108. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 2005, 8:233-246.
109. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 1989, 249:155-164.
110. Maj J., Bijak M., Dziedzicka-Wasylewska M., Rogoz R., Rogóz Z., Skuza G., Tokarski T. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology 1996, 127:73-82.
111. Maj J., Moryl E. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J. Neural. Transm. Gen. Sect. 1992, 88:143-156.
112. Maj J., Moryl E. Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists. Eur. Neuropsychopharmacol. 1993, 3:85-94.
113. Mansari el M., Bouchard C., Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology 1995, 13:117-127.
114. 2C receptor functions in mice. Eur. Neuropsychopharmacol. 2010, 20:S128.
115. 2C receptor function: relevance to anxiety and aggression in VGV mice. Mol. Psychiatry 2013, 18:656-665.
116. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 1998, 286:913-924.
117. 2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study. Mol. Psychiatry 2007, 12:797-798.
118. Masson J., Emerit M.B., Hamon M., Darmon M. Serotonergic signaling: multiple effectors and pleiotropic effects. WIREs Membr. Transp. Signal. 2012, 1:685-713.
119. 2A/2C receptor antagonists. Psychopharmacology 1997, 130:144-151.
120. 2C receptors. Psychopharmacology 1996, 123:333-339.
121. 2C receptor disrupts transactivation of the small G-protein RhoA. Mol. Pharmacol. 2004, 65:252-256.
122. Melia K.R., Ryabinin A.E., Schroeder R., Bloom F.E., Wilson M.C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J. Neurosci. 1994, 14:5929-5938.
123. Meloni E.G., Reedy C.L., Cohen B.M., Carlezon W.A. Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol. Psychiatry 2008, 63:832-839.
124. 2C receptor in humans. J. Neurosci. 2012, 32:9344-9350.
125. 2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 2005, 60:441-460.
126. 2C receptor blockade. Psychopharmacology 2005, 177:448-458.
127. (2C) receptors. Int. J. Neuropsychopharmacol. 2011, 14:768-783.
128. Mo B., Feng N., Renner K., Forster G. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res. Bull. 2008, 76:493-498.
129. 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors. Neuropharmacology 2010, 59:468-473.
130. 1B knock-out mice. Behav. Pharmacol. 2008, 19:661.
131. 2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment. J. Neurochem. 2010, 115:438-449.
132. 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol. Dis. 2010, 39:169-180.
133. 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur. Neuropsychopharmacol. 1996, 6:169-175.
134. 1C receptor activation in rats. Psychopharmacology 1993, 110:140-144.
135. 2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. BMC Pharmacol. 2011, 11:3.
136. 2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 2008, 33:237-246.
137. Ni Y.G., Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci U. S. A. 1997, 94:2036-2040.
138. 2 ligands on three mouse models of anxiety. Behav. Brain Res. 2003, 140:203-214.
139. Ninan P.T. The functional anatomy, neurochemistry, and pharmacology of anxiety. J. Clin. Psychiatry 1999, 60(Suppl. 22):12-17.
140. 2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 2001, 24:478-491.
141. 2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice. Behav. Brain Res. 2008, 187:72-79.
142. (2A/2C) receptor-mediated behavior in olfactory bulbectomized mice. Life Sci. 2013, 92:119-124.
143. (2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution. Mol. Psychiatry 2004, 9:55-64.
144. 2C receptor in vivo. Front. Neurosci. 2010, 4:26.
145. 2C receptor antagonists induce fast-onset antidepressant effects. Mol. Psychiatry 2013, 144. 10.1038/mp.2013.
146. (2C) receptors in human brain: effect of suicide. Neurochem. Res. 2006, 31:167-176.
147. Peroutka S.J., Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980, 210:88-90.
148. (2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed. Neuroscience 2012, 210:152-167.
149. Pohl R., Yeragani V.K., Balon R., Lycaki H. The jitteriness syndrome in panic disorder patients treated with antidepressants. J. Clin. Psychiatry 1988, 49:100-104.
150. Quérée P., Peters S., Sharp T. Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo. Br. J. Pharmacol. 2009, 158:1477-1485.
151. Quested D.J., Sargent P.A., Cowen P.J. SSRI treatment decreases prolactin and hyperthermic responses to mCPP. Psychopharmacology 1997, 133:305-308.
152. 1C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol 1993, 10:281-283.
153. 2C receptor levels. Eur. J. Pharmacol. 1994, 262:125-131.
154. Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Doran P.J., Eells J.R., Wallis P. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B TFMPP and mCPP. Behav. Pharmacol. 1992, 3:621-634.
155. 2C receptor agonist WAY-163909 in rodents. Psychopharmacology 2007, 192:159-170.
156. 2C receptor agonist WAY-161503. Brain Res. 2006, 1073-1074:240-251.
157. 2C receptor agonist, on intake of palatable food in mice. Pharmacol. Biochem. Behav. 2008, 91:176-180.
158. Rowland N.E., Robertson K., Green D.J. Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice. Physiol. Behav. 2003, 78:295-301.
159. Rowland N.E., Rokadia S., Green D.J., Robertson K. Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine. Pharmacol. Biochem. Behav. 2004, 77:541-546.
160. Rygula R., Abumaria N., Flügge G., Fuchs E., Rüther E., Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav. Brain Res. 2005, 162:127-134.
161. Rygula R., Abumaria N., Domenici E., Hiemke C., Fuchs E. Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav. Brain Res. 2006, 174:188-192.
162. 2C receptor internalization. J. Pharmacol Exp. Ther. 2004, 310:865-870.
163. 2C receptors: suicide, serotonin, and runaway RNA editing. Neuroscientist 2003, 9:237-242.
164. 2C receptors in GABAergic cells of the anterior raphe nuclei. J. Chem. Neuroanat. 2005, 29:83-91.
165. 2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine. Synapse 1997, 27:45-56.
166. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 1994, 116:56-64.
167. Spurlock G., Buckland P., O'Donovan M., McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 1994, 33:433-440.
168. (2C) receptor system: effector pathway and agonist dependence. J. Pharmacol. Exp. Ther. 2002, 302:957-962.
169. (2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats. Psychopharmacology 2009, 203:665-675.
170. To C.T., Anheuer Z.E., Bagdy G. Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. Neuroreport 1999, 10:553-555.
171. 2C receptor mRNA level in the rat brain. Neurosci. Res. 1996, 24:189-193.
172. 1D receptor involvement in OCD pathophysiology. Biol. Psychiatry. 2005, 57:1176-1185.
173. Ulrichsen J., Partilla J.S., Dax E.M. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology 1992, 107:229-235.
174. 2C receptors and their atypical regulation properties. Life Sci. 2003, 72:2429-2449.
175. 2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration. Int. J. Neuropsychopharmacol. 2011, 14:1-12.
176. 1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment. Neuropharmacology 2013, 79C:127-135.
177. Vickers S.P., Benwell K.R., Porter R.H., Bickerdike M.J., Kennett G.A., Dourish C.T. Comparative effects of continuous infusion of mCPP. RO 60,0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br. J. Pharmacol. 2000, 130:1305-1314.
178. 2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 2003, 167:274-280.
179. 2C and suicide victims. Genes Brain Behav. 2009, 8:541-545.
180. 2C receptors. J. Neurochem. 2000, 74:1290-1300.
181. 2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol. Ther. 2008, 119:7-23.
182. 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 1995, 48:200-205.
183. Wetzler S., Asnis G.M., DeLecuona J.M., Kalus O. Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine. Psychiatry Res. 1996, 64:77-82.
184. 2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 2001, 41:186-199.
185. Wozniak K.M., Aulakh C.S., Hill J.L., Murphy D.L. Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology 1989, 97:269-274.
186. Wright I.K., Heaton M., Upton N., Marsden C.A. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology 1992, 107:405-414.
187. 2C receptor-mediated hypolocomotion in rats. Pharmacol. Biochem. Behav. 2004, 78:683-689.
188. 2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res. Mol. Brain Res. 2004, 124:70-78.
189. Yau J.L., Olsson T., Noble J., Seckl J.R. Serotonin receptor subtype gene expression in the hippocampus of aged rats following chronic amitriptyline treatment. Brain Res. Mol. Brain Res. 1999, 70:282-287.
190. Zangrossi H., Viana M.B., Graeff F.G. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur. J. Pharmacol. 1999, 369:267-270.